Veeva Systems (VEEV): financials, SEC filings and peers
Veeva Systems (VEEV) is a health care technology company in the Health Care sector of the S&P 500, headquartered in Pleasanton, California.
It was founded in 2007 and joined the S&P 500 on May 7, 2026.
Its fiscal year ends in January, and its shares trade on the NYSE.
In its SEC filings it is classified as “Services-Prepackaged Software”.
Veeva Systems at a glance
- Revenue (12 months)
- $3.5B
- Revenue growth
- +16.5%
- Operating margin
- 29.9%
- Net income (12 months)
- $1.0B
- Free cash flow (12 months)
- —
- Cash
- $1.8B
- Debt
- —
- Diluted EPS (12 months)
- $6.11
Twelve months to July 31, 2026, from the 10-Q filed August 27, 2026.
Latest twelve months
Over the twelve months to July 31, 2026, Veeva Systems reported revenue of $3.5 billion, up 16.5% from a year earlier.
Its operating margin was 29.9%, up 3.0 percentage points from a year earlier: for every $100 of sales, about $30 was left as operating profit.
Net income was $1.0 billion (29.3% of revenue), 25.3% higher than a year earlier.
At the end of the period it held $1.8 billion in cash and not reported in debt, a net cash position of $1.8 billion.
The diluted share count fell 1.6% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $1.5 billion in fiscal 2021 to $3.2 billion in fiscal 2026, about 16.9% a year.
- Revenue has grown for 5 fiscal years in a row.
- Operating margin widened from 25.8% to 28.7% over the same years.
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.2B | $2.4B | $2.7B | $3.2B |
| Revenue growth | 26.3% | 16.4% | 9.7% | 16.2% | 16.3% |
| Operating margin | 27.3% | 21.3% | 18.2% | 25.2% | 28.7% |
| Net income | $427M | $488M | $526M | $714M | $909M |
| Free cash flow | — | — | — | — | — |
| Diluted EPS | $2.63 | $3.00 | $3.22 | $4.32 | $5.44 |
Fiscal years as reported in Veeva Systems’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed August 27, 2026 — quarterly report
- 8-K filed August 26, 2026 — Earnings results
- 8-K filed August 20, 2026 — Executive or director change
- 8-K filed June 18, 2026 — Shareholder vote results
- 10-Q filed June 5, 2026 — quarterly report
- 8-K filed June 3, 2026 — Earnings results
- 8-K filed April 20, 2026 — Executive or director change
- 10-K filed March 20, 2026 — annual report
Companies like Veeva Systems
Other S&P 500 companies in Health Care Technology:
More from Health Care
Questions about Veeva Systems
Is Veeva Systems's revenue growing?
Yes. Revenue for the twelve months to July 31, 2026 was $3.5 billion, up 16.5% from a year earlier, according to its SEC filings.
Is Veeva Systems profitable?
Yes. It earned $1.0 billion in net income over the twelve months to July 31, 2026, a net margin of 29.3%.
When did Veeva Systems last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on August 27, 2026.
Which companies are similar to Veeva Systems?
In the S&P 500, Veeva Systems is grouped in Health Care Technology within the Health Care sector. Solventum (SOLV) are in the same group.
Understand the numbers
Source: Veeva Systems’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.